Index RUT P/E 30.99 EPS (ttm) 4.21 Insider Own 1.76% Shs Outstand 18.10M Perf Week 0.24%
Market Cap 2.36B Forward P/E 22.30 EPS next Y 5.85 Insider Trans -14.71% Shs Float 17.78M Perf Month -1.52%
Income 68.90M PEG 2.56 EPS next Q 1.30 Inst Own 98.00% Short Float 2.16% Perf Quarter 10.12%
Sales 1.11B P/S 2.12 EPS this Y 14.07% Inst Trans 2.18% Short Ratio 2.47 Perf Half Y 28.77%
Book/sh 50.92 P/B 2.56 EPS next Y 11.97% ROA 6.74% Short Interest 0.38M Perf Year 53.31%
Cash/sh 9.58 P/C 13.62 EPS next 5Y 12.10% ROE 8.68% 52W Range 78.35 - 136.12 Perf YTD 40.48%
Dividend Est. - P/FCF 23.80 EPS past 5Y 23.63% ROI 7.18% 52W High -4.17% Beta 1.04
Dividend TTM - Quick Ratio 2.00 Sales past 5Y 15.56% Gross Margin 31.25% 52W Low 66.48% ATR (14) 2.85
Dividend Ex-Date - Current Ratio 2.00 EPS Y/Y TTM 26.94% Oper. Margin 9.49% RSI (14) 52.85 Volatility 2.30% 1.95%
Employees 34846 Debt/Eq 0.05 Sales Y/Y TTM 11.57% Profit Margin 6.18% Recom 1.50 Target Price 133.44
Option/Short Yes / Yes LT Debt/Eq 0.04 EPS Q/Q 20.14% Payout 0.00% Rel Volume 2.67 Prev Close 133.05
Sales Surprise 0.71% EPS Surprise 11.18% Sales Q/Q 10.36% Earnings Aug 05 AMC Avg Volume 155.04K Price 130.44
SMA20 -0.26% SMA50 3.02% SMA200 22.00% Trades
Volume 414,124 Change -1.96%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-28-24 Initiated Macquarie
Outperform
$136
Apr-23-24 Downgrade Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated Barclays
Equal Weight
$88
Feb-05-24 Resumed William Blair
Outperform
Dec-12-23 Initiated TD Cowen
Outperform
$105
Jun-29-22 Initiated Stifel
Buy
$101
Apr-13-22 Initiated BofA Securities
Buy
$110
Oct-22-19 Resumed Stephens
Overweight
Jun-27-19 Initiated BMO Capital Markets
Market Perform
Feb-04-19 Upgrade Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated Jefferies
Buy
$75
Aug-20-18 Initiated Raymond James
Outperform
$75
Sep-30-14 Upgrade Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated Robert W. Baird
Outperform
$13
Dec-07-09 Initiated Oppenheimer
Outperform
$12
Show Previous Ratings
Sep-17-24 09:30AM
Sep-16-24 08:29AM
Sep-13-24 07:00PM
07:00PM
Sep-12-24 01:04AM
07:01PM
Loading…
Sep-03-24 07:01PM
Aug-28-24 07:00PM
Aug-05-24 09:54PM
06:30PM
05:35PM
04:32PM
(Associated Press Finance)
04:05PM
Jul-22-24 11:00AM
10:01AM
Jun-28-24 04:01PM
08:45PM
Loading…
Jun-26-24 08:45PM
04:01PM
Jun-17-24 02:47PM
Jun-10-24 08:00AM
May-29-24 11:00AM
09:00AM
May-21-24 08:00AM
May-09-24 09:15AM
May-08-24 04:04PM
03:24AM
May-07-24 11:00AM
09:19AM
06:11AM
May-06-24 06:33PM
06:30PM
06:05PM
Loading…
06:05PM
05:03PM
(Associated Press Finance)
04:05PM
May-02-24 09:40AM
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
Feb-21-24 09:15AM
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Oct-17-23 06:21AM
Oct-16-23 12:00PM
08:58AM
Oct-10-23 09:40AM
Oct-03-23 11:40AM
Sep-25-23 03:21AM
Sep-24-23 10:30AM
Aug-02-23 04:05PM
Aug-01-23 08:00AM
Jul-31-23 06:25PM
05:12PM
04:05PM
Jul-29-23 11:30AM
Jul-24-23 10:00AM
Jul-23-23 09:03AM
Jul-20-23 12:10PM
Jul-17-23 01:00PM
Jul-03-23 01:01PM
Jun-29-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-09-23 01:39PM
Jun-08-23 12:44PM
Jun-07-23 01:53PM
12:52PM
Jun-06-23 10:20AM
Jun-05-23 02:12PM
11:45AM
11:40AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:04PM
May-29-23 09:55AM
May-26-23 10:55AM
May-25-23 02:30PM
09:35AM
May-24-23 01:42PM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
POFF BRIAN EVP/Chief Financial Officer Sep 12 '24 Sale 128.62 6,839 879,655 24,705 Sep 13 04:30 PM GAFFNEY SEAN EVP / Chief Legal Officer Sep 12 '24 Sale 129.15 2,962 382,542 15,040 Sep 13 04:30 PM GAFFNEY SEAN Officer Sep 12 '24 Proposed Sale 129.15 2,962 382,542 Sep 12 05:27 PM BRIAN POFF Officer Sep 12 '24 Proposed Sale 128.62 6,839 879,634 Sep 12 04:11 PM Lopez Esteban Director Sep 10 '24 Sale 127.50 500 63,750 3,366 Sep 11 04:30 PM Lopez Esteban Director Sep 04 '24 Sale 130.03 500 65,015 3,866 Sep 06 04:30 PM BICKHAM W BRADLEY President and COO Aug 29 '24 Sale 132.15 3,520 465,168 44,480 Sep 03 04:30 PM BICKHAM W BRADLEY President and COO Aug 30 '24 Sale 132.26 1,480 195,745 43,000 Sep 03 04:30 PM BICKHAM W BRADLEY Officer Aug 29 '24 Proposed Sale 132.00 5,000 660,000 Aug 29 05:08 PM Lopez Esteban Director Aug 29 '24 Proposed Sale 134.00 1,000 134,000 Aug 29 04:08 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 26 '24 Option Exercise 87.80 20,000 1,756,000 29,132 Aug 28 04:30 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 26 '24 Sale 133.29 21,917 2,921,267 7,215 Aug 28 04:30 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 26 '24 Option Exercise 85.36 13,133 1,121,079 23,630 Aug 28 04:30 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 26 '24 Sale 133.13 15,285 2,034,953 8,345 Aug 28 04:30 PM BLESSING CLIFF DONALD EVP/Chief Development Officer Aug 26 '24 Sale 133.50 1,600 213,592 7,379 Aug 28 04:30 PM TUCKER DAVID W. Officer Aug 26 '24 Proposed Sale 131.00 15,285 2,002,335 Aug 26 05:04 PM BLESSING CLIFF DONALD Officer Aug 26 '24 Proposed Sale 133.00 1,600 212,800 Aug 26 05:02 PM WATTENBARGER MICHAEL D. Officer Aug 26 '24 Proposed Sale 130.00 21,917 2,849,210 Aug 26 04:58 PM Stevenson Roberton James EVP & Chief HR Officer Jun 17 '24 Sale 116.13 217 25,200 10,217 Jun 18 04:05 PM Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM RAINES MONICA EVP/CCO and Quality Officer Mar 04 '24 Sale 93.86 235 22,057 11,986 Mar 05 04:09 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 26 '24 Sale 85.95 1,176 101,077 9,132 Feb 27 04:10 PM POFF BRIAN EVP/Chief Financial Officer Feb 26 '24 Sale 85.95 4,814 413,763 31,544 Feb 27 04:10 PM ALLISON R DIRK CEO and Chairman Feb 26 '24 Sale 85.95 8,021 689,405 79,397 Feb 27 04:10 PM Stevenson Roberton James EVP & Chief HR Officer Feb 26 '24 Sale 85.95 714 61,368 10,543 Feb 27 04:10 PM BICKHAM W BRADLEY President and COO Feb 26 '24 Sale 85.95 5,212 447,971 48,000 Feb 27 04:10 PM RAINES MONICA EVP/CCO and Quality Officer Feb 26 '24 Sale 85.96 538 46,246 12,221 Feb 27 04:10 PM GAFFNEY SEAN EVP/Chief Legal Officer Feb 26 '24 Sale 85.95 1,639 140,872 18,002 Feb 27 04:10 PM TUCKER DAVID W. EVP/Chief Strategy Officer Feb 26 '24 Sale 85.96 1,347 115,788 10,497 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Feb 26 '24 Sale 85.94 1,763 151,512 40,754 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Option Exercise 23.10 9,690 223,839 46,550 Nov 16 04:39 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Sale 85.00 9,690 823,650 36,860 Nov 16 04:39 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Nov 08 '23 Sale 83.45 235 19,611 5,987 Nov 09 05:14 PM TUCKER DAVID W. EVP / Chief Strategy Officer Nov 08 '23 Sale 83.45 248 20,696 6,973 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Option Exercise 23.10 3,008 69,485 39,868 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Sale 85.00 3,008 255,680 36,860 Nov 09 05:13 PM
Index RUT P/E - EPS (ttm) -0.03 Insider Own 1.59% Shs Outstand 50.77M Perf Week 0.46%
Market Cap 3.53B Forward P/E 82.34 EPS next Y 0.84 Insider Trans 0.00% Shs Float 50.30M Perf Month 0.07%
Income -1.71M PEG - EPS next Q 0.11 Inst Own 83.98% Short Float 6.91% Perf Quarter 2.34%
Sales 408.81M P/S 8.65 EPS this Y 317.14% Inst Trans 3.75% Short Ratio 10.48 Perf Half Y 1.29%
Book/sh 12.61 P/B 5.48 EPS next Y 222.29% ROA -0.25% Short Interest 3.48M Perf Year 17.70%
Cash/sh 6.72 P/C 10.29 EPS next 5Y - ROE -0.28% 52W Range 48.30 - 69.68 Perf YTD 11.12%
Dividend Est. - P/FCF 186.84 EPS past 5Y 36.15% ROI -0.25% 52W High -0.76% Beta 0.82
Dividend TTM - Quick Ratio 7.11 Sales past 5Y 541.82% Gross Margin 73.68% 52W Low 43.17% ATR (14) 0.36
Dividend Ex-Date - Current Ratio 8.96 EPS Y/Y TTM 95.66% Oper. Margin -1.25% RSI (14) 58.22 Volatility 0.56% 0.46%
Employees 797 Debt/Eq 0.05 Sales Y/Y TTM 27.81% Profit Margin -0.42% Recom 2.80 Target Price 71.57
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q 190.04% Payout - Rel Volume 2.31 Prev Close 69.25
Sales Surprise 1.53% EPS Surprise 32.38% Sales Q/Q 23.33% Earnings Aug 01 AMC Avg Volume 331.68K Price 69.15
SMA20 0.29% SMA50 0.78% SMA200 3.28% Trades
Volume 766,323 Change -0.14%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-09-24 Downgrade Wolfe Research
Outperform → Peer Perform
Jul-19-23 Initiated Robert W. Baird
Outperform
$69
Jul-13-23 Initiated KeyBanc Capital Markets
Overweight
$70
May-23-23 Initiated CL King
Buy
$75
Apr-14-23 Initiated Mizuho
Buy
$75
Mar-24-23 Upgrade Needham
Hold → Buy
$71
Oct-21-22 Initiated RBC Capital Mkts
Outperform
$85
Oct-12-22 Initiated Jefferies
Hold
$75
Oct-10-22 Downgrade Needham
Buy → Hold
Apr-06-22 Initiated Wolfe Research
Outperform
$69
Mar-02-22 Resumed BofA Securities
Buy
$70
Jul-12-21 Initiated Barclays
Overweight
$74
Jun-28-21 Reiterated Needham
Buy
$72 → $78
Nov-05-20 Reiterated Needham
Buy
$57 → $62
Oct-23-20 Initiated Guggenheim
Buy
$77
Sep-02-20 Initiated Robert W. Baird
Outperform
$52
Aug-07-20 Reiterated Needham
Buy
$48 → $57
Jan-08-20 Initiated SunTrust
Buy
$38
Nov-01-19 Initiated Piper Jaffray
Overweight
$39
Oct-21-19 Initiated Barclays
Overweight
$43
Show Previous Ratings
Sep-18-24 06:59PM
Aug-01-24 05:25PM
04:23PM
(Associated Press Finance)
04:01PM
May-29-24 06:05AM
04:01PM
Loading…
May-16-24 04:01PM
Apr-30-24 09:56PM
04:08PM
(Associated Press Finance)
04:01PM
Apr-25-24 10:25AM
Apr-24-24 06:30AM
Mar-29-24 12:00PM
Mar-22-24 04:01PM
Mar-21-24 04:54PM
Mar-15-24 08:53AM
06:00AM
Loading…
Mar-14-24 06:00AM
Feb-29-24 04:01PM
Feb-28-24 07:01PM
05:40PM
04:41PM
(Associated Press Finance)
04:01PM
Feb-02-24 09:09PM
Jan-31-24 06:30AM
Jan-29-24 11:02PM
Jan-25-24 08:07AM
Jan-23-24 02:45PM
Jan-10-24 03:07PM
Jan-08-24 07:38PM
11:28AM
07:58AM
(The Wall Street Journal)
07:00AM
Loading…
07:00AM
07:00AM
07:00AM
Dec-27-23 04:01PM
Nov-20-23 09:55AM
Nov-06-23 12:00PM
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM
04:28PM
(Associated Press Finance)
04:01PM
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COHEN RAYMOND W Chief Executive Officer Jul 24 '24 Option Exercise 22.94 103,896 2,382,878 292,731 Jul 25 07:33 PM Sama Rinda Chief Operating Officer Jan 31 '24 Option Exercise 0.00 28,000 0 83,854 Feb 02 06:00 PM Noblett Karen Chief Medical Officer Jan 31 '24 Option Exercise 0.00 27,500 0 45,716 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 31 '24 Sale 67.74 11,288 764,603 34,428 Feb 02 05:59 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Option Exercise 0.00 28,000 0 93,302 Feb 02 05:59 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Sale 67.74 15,899 1,076,933 77,403 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Option Exercise 0.00 25,500 0 60,065 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Sale 67.74 16,615 1,125,432 43,450 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Option Exercise 0.00 6,167 0 46,812 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Sale 67.74 3,489 236,331 43,323 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Option Exercise 0.00 63,400 0 223,996 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Sale 67.74 35,161 2,381,662 188,835 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 08 '24 Sale 69.00 15,999 1,103,961 18,216 Jan 10 08:00 PM Noblett Karen Chief Medical Officer Dec 28 '23 Sale 63.28 7,051 446,177 34,215 Dec 28 07:17 PM Noblett Karen Chief Medical Officer Dec 26 '23 Sale 63.00 949 59,787 41,266 Dec 28 07:17 PM Dearen Danny L. President & CFO Sep 29 '23 Option Exercise 0.00 11,250 0 31,452 Oct 03 07:37 PM Dearen Danny L. President & CFO Sep 29 '23 Sale 56.87 7,675 436,490 23,777 Oct 03 07:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
